Clinical Trials Browser

Phase 3 × Neoplasms × olaparib × Clear all

NCT04421963 2026-01-21

ROSY-O

Phase 3 Active not recruiting

BreastGynecologic

Breast Neoplasms, Neoplasms, Ovarian Neoplasms